Skip to main content
Tech.euFundingExplorerBeta

Camena

A synthetic biology company that developed a technology that overcomes these limitations by using a wholly novel enzymatic technology to accurately produce synthetic DNA

Total raised
€9.2M
€9,200,000
Funding rounds
1
Investors
1
distinct backers
Active since
2023-07
latest 2023-07

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood32
base rate 44% for Series A
  • Overdue vs cohort gap
  • Low backer re-investment

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2023-07-03Series A€9.2MMerciaView deal →

Investors

1

Related news

Similar companies

same sector or country
  • Nscale
    UK · Cloud
    €5.0B
  • Arm
    UK · Semiconductors
    €4.7B
  • DAZN
    UK · Software
    €3.8B
  • SumUp
    UK · Fintech
    €3.5B
  • CityFibre
    UK · Telecom
    €3.0B
  • Philips
    Netherlands · Healthtech
    €2.6B